No overall benefit with aspirin in a primary prevention setting of diabetes patientsAug. 27, 2018 - Prof. Jane Armitage, Oxford, UK
This 3-minute education provides a summary of just presented scientific data, recorded during the ESC 2018 congress. The objective is to provide a brief commentary and potential implications of these findings.
Professor Armitage’s (Oxford, United Kingdom) main research interests are in lipids and the epidemiology of cardiovascular and other chronic diseases including osteoporosis. She also has particular experience in respiratory medicine, geriatrics and diabetes. She has co-ordinated and been chief investigator for a series of large-scale randomised clinical trials in cardiovascular disease.
The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of ipccs.org. Ipccs.org did not receive financial support for the production of this 3-minute education.